Medical News

RSS

Synthetic Biologics announces initiation of SYN-010 Phase 2 clinical trial for treatment of IBS-C

Synthetic Biologics, Inc., a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, reported the initiation of a Phase 2 clinical trial of its proprietary SYN-010 for the treatment of irritable bowel syndrome with constipation (IBS-C).

29 Jun 2015

Tris, Pfizer Consumer Healthcare sign agreement to market extended-release Robitussin for treatment of cough

Tris Pharma, Inc. today announced that it has entered into a license, supply, and distribution agreement with Pfizer Consumer Healthcare.

29 Jun 2015

U.S. medical imaging market estimated to reach $82 million by 2019

Medical imaging is a notoriously data intensive field with its volume, variety and speed of data generation multiplying every day. Conventional tools are incapable of efficiently managing such large and complex datasets; posing limits on scalability, sustainability and usability. As the U.S. medical imaging field evolves from being not only data-intensive but also data-driven, big data tools are expected to better handle medical imaging, patient records, and improve workflow efficiency, diagnostic accuracy, treatment decisions and health management.

29 Jun 2015

Veracyte named to Bay Area News Group's Top Workplaces list for second consecutive year

Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has been named to the Bay Area News Group's prestigious Top Workplaces list for the second year in a row. The news group selects Top Workplace winners based solely on an annual survey of Bay Area-company employees.

29 Jun 2015

Global GBM therapeutics market to expand at CAGR of 10.9% to $623 million by 2020

According to analysis from business intelligence provider GBI Research - Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - the value of the global Glioblastoma Multiforme (GBM) treatment market will expand at a rapid Compound Annual Growth Rate (CAGR) of 10.9%, from $301 million in 2013 to $623 million by 2020.

29 Jun 2015

Can-Fite reports further progress in continuing preclinical program of CF602 sexual dysfunction drug

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.

29 Jun 2015

Scientists examine rates of secondary mutations in biomarker genes

Many tests for predictive biomarkers in tumors focus on selected known mutations or regions (e.g. hotspot panels). In a new study, scientists at Molecular Health examined the rates of secondary mutations in known biomarker genes and their potential impact on the diagnostic reliability of specific single-nucleotide variant (SNV) biomarker testing.

29 Jun 2015

Researchers reconstruct infants' visual perception of the world

A newborn infant can see its parents' expressions at a distance of 30 cm. For the first time researchers have managed to reconstruct infants visual perception of the world.

29 Jun 2015

People with specific gene variant at greater risk of developing depressions

People born with a particular gene variant have a greater risk of developing depressions, a recent study from the Department of Psychology at The University of Oslo shows.

29 Jun 2015

Study opens up new line of research into origin of digestive diseases

There are numerous studies related to the absorption of nutrients from the stomach since understanding what happens in our digestive system is crucial, for example, in order to be able to avoid in the future some of the diseases that affect part of the population to a lesser or greater extent.

29 Jun 2015

New 3-step solution could help parents banish their children's fussy eating habits

Parents could banish their children's fussy eating habits by following three simple steps, a new study suggests. Introducing the 'three Rs' - Repetition, Role Modelling and Rewards - at meal times could help parents to get their children to eat, and even like, new vegetables, according to new research from Aston and Loughborough Universities.

29 Jun 2015

Canadian Partnership Against Cancer launches landmark health data portal

A landmark research portal that includes health and biological data from 300,000 Canadians — nearly one in every 50 individuals between the ages of 35 and 69 – is being launched today by the Canadian Partnership Against Cancer (the Partnership).

29 Jun 2015

Egalet reports positive results from Category 3 abuse-deterrent intranasal HAL study

Egalet Corporation today announced positive results from a Category 3 intranasal human abuse liability (HAL) study of Egalet-001, an abuse-deterrent, extended-release, oral morphine formulation in late-stage clinical development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.

29 Jun 2015

Falcon Physician wins Gold Stevie Award in Information Technology Department of the Year category

Falcon Physician was presented with a Gold Stevie Award in the Information Technology Department of the Year category at the 13th Annual American Business Awards in Chicago.

29 Jun 2015

New survey sheds light on the way Americans think about their brain health, lifestyle habits

Is your brain important to you? Do you know how to keep it healthy? According to a recent survey conducted by Reader’s Digest in partnership with the Alzheimer’s Association, 91 percent of people believe they can reduce their risk of cognitive decline, but they have misconceptions about ways to keep their brains healthy.

29 Jun 2015

Cosmederm Bioscience expands TriCalm's line of anti-itch products to further benefit sufferers of itch

Cosmederm Bioscience, Inc. today announced the expansion of its itch-relief product line, TriCalm, with the new TriCalm Clinical Repair Cream and TriCalm Extra Strength Spray. Following the success of the company's initial product, TriCalm Hydrogel, these two new offerings strategically expand the brand's line of steroid-free, anti-itch products to further benefit sufferers of itch.

29 Jun 2015

STEM Learning launches Mini Science Centres as part of their CSR programme

Corporates today are on the lookout of new and novel ways to use their CSR funds effectively. A genuine step towards improving the quality of education in urban and especially rural areas would definitely interest them. And to make this possible, STEM Learning Pvt Ltd has launched Mini Science Centres (MSC) to promote experiential learning.

29 Jun 2015

Scientists identify association between coronary heart disease and osteoporosis

University of Southampton scientists have discovered a link between coronary heart disease and osteoporosis, suggesting both conditions could have similar causes.

29 Jun 2015

Elsevier announces highlights of 2014 Impact Factor performance

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the highlights of its journal Impact Factor performance in 2014. According to the 2014 Journal Citation Reports (JCR) published by Thomson Reuters, Elsevier saw 55% of its journal Impact Factors increase from 2013 to 2014, ahead of the aggregate across other journals.

29 Jun 2015

Hiroshima University researchers develop accurate method to detect drug resistant HCV mutation

A rapid, sensitive, and accurate method to detect drug resistant hepatitis C virus (HCV) mutants has been developed. Researchers at Hiroshima University established a system to rapidly and accurately measure the presence of HCV Y93H drug resistant mutant strains, and evaluate the proportion of patients harboring this mutation prior to treatment.

29 Jun 2015

Medical News

Synthetic Biologics announces initiation of SYN-010 Phase 2 clinical trial for treatment of IBS-C

Tris, Pfizer Consumer Healthcare sign agreement to market extended-release Robitussin for treatment of cough

U.S. medical imaging market estimated to reach $82 million by 2019

Veracyte named to Bay Area News Group's Top Workplaces list for second consecutive year

Global GBM therapeutics market to expand at CAGR of 10.9% to $623 million by 2020

Can-Fite reports further progress in continuing preclinical program of CF602 sexual dysfunction drug

Scientists examine rates of secondary mutations in biomarker genes

Researchers reconstruct infants' visual perception of the world

People with specific gene variant at greater risk of developing depressions

Study opens up new line of research into origin of digestive diseases

New 3-step solution could help parents banish their children's fussy eating habits

Canadian Partnership Against Cancer launches landmark health data portal

Egalet reports positive results from Category 3 abuse-deterrent intranasal HAL study

Falcon Physician wins Gold Stevie Award in Information Technology Department of the Year category

New survey sheds light on the way Americans think about their brain health, lifestyle habits

Cosmederm Bioscience expands TriCalm's line of anti-itch products to further benefit sufferers of itch

STEM Learning launches Mini Science Centres as part of their CSR programme

Scientists identify association between coronary heart disease and osteoporosis

Elsevier announces highlights of 2014 Impact Factor performance

Hiroshima University researchers develop accurate method to detect drug resistant HCV mutation

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News